Avestar Capital, LLC Biogen Inc. Transaction History

Avestar Capital, LLC

$965 Million
Q2 2024

A detailed history of Avestar Capital, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Avestar Capital, LLC holds 2,488 shares of BIIB stock, worth $432,389. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,488

Previous 2,034 22.32%

Holding current value

$432,389

Previous $438,000 31.51%

% of portfolio

0.06%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$190.52 - $236.72 $86,496 - $107,470	454 Added 22.32%	2,488 $576,000
Q1 2024 May 10, 2024	SELL	$212.02 - $267.71 $21,838 - $27,574	-103 Reduced 4.82%	2,034 $438,000
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $23,371 - $28,133	105 Added 5.17%	2,137 $552,000
Q3 2023 Oct 20, 2023	BUY	$253.3 - $285.89 $6,079 - $6,861	24 Added 1.2%	2,032 $522,000
Q2 2023 Aug 01, 2023	BUY	$275.25 - $318.06 $36,883 - $42,620	134 Added 7.15%	2,008 $571,000
Q1 2023 Apr 20, 2023	BUY	$256.56 - $292.34 $25,399 - $28,941	99 Added 5.58%	1,874 $521,000
Q4 2022 Jan 20, 2023	BUY	$252.44 - $306.72 $3,534 - $4,294	14 Added 0.8%	1,775 $0
Q3 2022 Oct 26, 2022	SELL	$194.69 - $268.46 $61,132 - $84,296	-314 Reduced 15.13%	1,761 $470,000
Q2 2022 Jul 28, 2022	SELL	$187.54 - $223.02 $123,588 - $146,970	-659 Reduced 24.1%	2,075 $423,000
Q1 2022 Apr 26, 2022	BUY	$193.77 - $244.14 $25,771 - $32,470	133 Added 5.11%	2,734 $576,000
Q4 2021 Feb 01, 2022	BUY	$223.92 - $287.77 $157,415 - $202,302	703 Added 37.04%	2,601 $624,000
Q3 2021 Nov 09, 2021	BUY	$282.99 - $369.05 $5,093 - $6,642	18 Added 0.96%	1,898 $537,000
Q2 2021 Aug 03, 2021	SELL	$259.0 - $414.71 $30,044 - $48,106	-116 Reduced 5.81%	1,880 $651,000
Q1 2021 May 03, 2021	BUY	$242.95 - $284.63 $34,984 - $40,986	144 Added 7.78%	1,996 $534,000
Q4 2020 Feb 01, 2021	BUY	$236.26 - $355.63 $19,845 - $29,872	84 Added 4.75%	1,852 $453,000
Q3 2020 Oct 29, 2020	SELL	$264.77 - $305.71 $37,862 - $43,716	-143 Reduced 7.48%	1,768 $454,000
Q2 2020 Jul 29, 2020	SELL	$258.66 - $342.55 $66,992 - $88,720	-259 Reduced 11.94%	1,911 $511,000
Q1 2020 May 12, 2020	BUY	$268.85 - $341.04 $62,104 - $78,780	231 Added 11.91%	2,170 $687,000
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $36,750 - $50,779	-167 Reduced 7.93%	1,939 $575,000
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $1,087 - $1,219	-5 Reduced 0.24%	2,106 $490,000
Q2 2019 Aug 06, 2019	SELL	$219.29 - $241.72 $21,490 - $23,688	-98 Reduced 4.44%	2,111 $473,000
Q1 2019 May 09, 2019	SELL	$216.71 - $338.96 $26,005 - $40,675	-120 Reduced 5.15%	2,209 $502,000
Q4 2018 Jan 25, 2019	SELL	$278.5 - $352.75 $41,775 - $52,912	-150 Reduced 6.05%	2,329 $675,000
Q3 2018 Oct 23, 2018	BUY	$293.51 - $383.83 $14,969 - $19,575	51 Added 2.1%	2,479 $852,000
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $73,908 - $88,083	287 Added 13.4%	2,428 $685,000
Q1 2018 May 10, 2018	BUY	$260.13 - $367.91 $40,060 - $56,658	154 Added 7.75%	2,141 $563,000
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $611,280 - $684,680	1,987	1,987 $618,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.

Account

Avestar Capital, LLC Biogen Inc. Transaction History